March 02, 2015 12:57 AM ET


Company Overview of NuPathe, Inc.

Executive Profile

Armando Anido

Chairman and Chief Executive Officer, Zynerba Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 6 different industries.

See Board Relationships


Mr. Armando Anido has been the Chairman and Chief Executive Officer at Zynerba Pharmaceuticals, Inc. since October 2014. Mr. Anido has more than 30 years of executive, operational and commercial leadership experience in the biopharmaceutical industry. He served as the Chief Executive Officer at NuPathe, Inc., since July 2012. He served as the Chief Executive and President of Auxilium Pharmaceuticals Inc. from July 17, 2006 to December 7, 2011. Mr. Anido joined Auxilium ...

Corporate Headquarters

7 Great Valley Parkway
Malvern, Pennsylvania 19355

United States

Phone: 610-232-0800
Fax: 610-232-0571

Board Members Memberships

Chairman and Chief Executive Officer
Director and Chairman of Governance & Nominating Committee
Former Chief Executive Officer, President and Director
Independent Board Member


West Virginia University
West Virginia University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NuPathe, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at